Cardiovascular Surgery Devices And Equipment Market Size and Forecast 2024-2033| Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics

Overview and Scope

Cardiovascular surgery devices and equipment are used in cardiac surgery and other cardiovascular procedures performed to repair structural defects of the cardiovascular system and damaged or blocked valves and vessels.

Sizing and Forecast

The cardiovascular surgery devices and equipment market size has grown steadily in recent years. It will grow from <b>$1.79 billion in 2023 to $1.87 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. </b> The growth in the historic period can be attributed to prevalence of cardiovascular diseases, technological advancements, aging population, chronic disease management.

The cardiovascular surgery devices and equipment market size is expected to see steady growth in the next few years. It will grow to <b>$2.16 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. </b> The growth in the forecast period can be attributed to minimally invasive surgery, advanced imaging, personalized medicine, telemedicine and teleconsultations. Major trends in the forecast period include hybrid operating rooms, transcatheter procedures, artificial intelligence (ai) in surgery, remote surgical training.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-repor

Segmentation & Regional Insights

The cardiovascular surgery devices and equipment market covered in this report is segmented –

1) By Product Type: Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables

2) By Application: Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications

3) By End User: Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories

<b>North America</b> was the largest region in the global cardiovascular surgery devices and equipment market in 2023. <b>Western Europe</b> was the second-largest region in the global cardiovascular surgery devices and equipment market. The regions covered in the cardiovascular surgery devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2389&type=smp

Major Driver Impacting Market Growth

The rising geriatric population along with the rising deaths related to cardiovascular disorders is driving the cardiovascular surgical devices market. According to American Heart Association (AHA), in the US, approximately 43.7 million aged above 60 suffered from cardiovascular disorders. It is also reported by AHA that death related to cardiac diseases amount to 17.3 million per year and is expected to rise to more than 23.6 million by 2030, worldwide. Due to these factors, a higher number of surgeries are being performed, thereby driving the market.

Key Industry Players

Major companies operating in the cardiovascular surgery devices and equipment market include <b> Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Abiomed Inc., Angiodynamics, Transmedics, Terumo cardiovascular systems corporation, Edwards Life Science Corporation, Medtronic plc, Cardinal Health, Cyberheart Incorporated, Medwaves Incorporated, Thoratec Corporation, Cordis Corporation, Getinge Group, Atrion Corporation, Sorin S.P.A., Biosensors International, Bioventrix Inc., Maquet GmbH & Co. KG, EndoPhotonix Inc., Krdium Inc., SEMMT Inc., Amaranth Medical, 3M Health Care, Abaxis Inc., Atlas Genetics, Becton Dickinson and Company, BioFire Diagnostics, bioMérieux, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, EKF Diagnostics, GenMark Diagnostics, Hologic, LumiraDx, Mesa Biotech (a subsidiary of Thermo Fisher Scientific), Nova Biomedical, NOWDiagnostics, Opko Health, OraSure Technologies, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Trividia Health, Trivitron Healthcare, Werfen S.A. </b>

The cardiovascular surgery devices and equipment market report table of contents includes:

1. Executive Summary

2. Cardiovascular Surgery Devices And Equipment Market Characteristics

3. Cardiovascular Surgery Devices And Equipment Market Trends And Strategies

4. Cardiovascular Surgery Devices And Equipment Market – Macro Economic Scenario

5. Global Cardiovascular Surgery Devices And Equipment Market Size and Growth

.

.

.

26. South America Cardiovascular Surgery Devices And Equipment Market

27. Brazil Cardiovascular Surgery Devices And Equipment Market

28. Middle East Cardiovascular Surgery Devices And Equipment Market

29. Africa Cardiovascular Surgery Devices And Equipment Market

30. Cardiovascular Surgery Devices And Equipment Market Competitive Landscape And Company Profiles

Top Major Players:

• Abbott Laboratories
• Boston Scientific Corporation
• Cook Medical
• Abiomed Inc
• Angiodynamics

Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model